Post-IPO Equity - Merck
Investment Firm
Overview
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Announced Date
Nov 25, 2018
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Merck raised $586000 on 2018-11-25 in Post-IPO Equity
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 25, 2018 |  Post-IPO Equity - Merck | 1 | - | 586.0K |
| Jan 21, 2016 | Venture Round - Merck | 1 | - | 5.0M |
Recent Activity
There is no recent news or activity for this profile.